First Time Loading...
C

Clarus Therapeutics Holdings Inc
NASDAQ:CRXT

Watchlist Manager
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Watchlist
Price: 0.021 USD -19.54% Market Closed
Updated: May 29, 2024

Clarus Therapeutics Holdings Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Clarus Therapeutics Holdings Inc
Other Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
C
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Other Liabilities
$1.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Other Liabilities
$25B
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
5%
Bristol-Myers Squibb Co
NYSE:BMY
Other Liabilities
$6.7B
CAGR 3-Years
-4%
CAGR 5-Years
6%
CAGR 10-Years
9%
Pfizer Inc
NYSE:PFE
Other Liabilities
$25.8B
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
Other Liabilities
$8.3B
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Other Liabilities
$7.9B
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
6%

See Also

What is Clarus Therapeutics Holdings Inc's Other Liabilities?
Other Liabilities
1.6m USD

Based on the financial report for Dec 31, 2021, Clarus Therapeutics Holdings Inc's Other Liabilities amounts to 1.6m USD.

What is Clarus Therapeutics Holdings Inc's Other Liabilities growth rate?
Other Liabilities CAGR 1Y
-83%

Over the last year, the Other Liabilities growth was -83%.